1. Home
  2. VRAX vs SBEV Comparison

VRAX vs SBEV Comparison

Compare VRAX & SBEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • SBEV
  • Stock Information
  • Founded
  • VRAX 2013
  • SBEV 1992
  • Country
  • VRAX United Kingdom
  • SBEV United States
  • Employees
  • VRAX N/A
  • SBEV N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SBEV Beverages (Production/Distribution)
  • Sector
  • VRAX Health Care
  • SBEV Consumer Staples
  • Exchange
  • VRAX Nasdaq
  • SBEV Nasdaq
  • Market Cap
  • VRAX 17.2M
  • SBEV 20.2M
  • IPO Year
  • VRAX 2022
  • SBEV N/A
  • Fundamental
  • Price
  • VRAX $2.80
  • SBEV $0.26
  • Analyst Decision
  • VRAX
  • SBEV Strong Buy
  • Analyst Count
  • VRAX 0
  • SBEV 4
  • Target Price
  • VRAX N/A
  • SBEV $1.75
  • AVG Volume (30 Days)
  • VRAX 13.0M
  • SBEV 734.4K
  • Earning Date
  • VRAX 11-06-2024
  • SBEV 08-14-2024
  • Dividend Yield
  • VRAX N/A
  • SBEV N/A
  • EPS Growth
  • VRAX N/A
  • SBEV N/A
  • EPS
  • VRAX N/A
  • SBEV N/A
  • Revenue
  • VRAX $156,419.00
  • SBEV $10,419,936.00
  • Revenue This Year
  • VRAX $5,169.18
  • SBEV N/A
  • Revenue Next Year
  • VRAX $66.97
  • SBEV $150.72
  • P/E Ratio
  • VRAX N/A
  • SBEV N/A
  • Revenue Growth
  • VRAX 1727.11
  • SBEV N/A
  • 52 Week Low
  • VRAX $0.60
  • SBEV $0.20
  • 52 Week High
  • VRAX $9.00
  • SBEV $0.79
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 46.62
  • SBEV 38.13
  • Support Level
  • VRAX $2.40
  • SBEV $0.26
  • Resistance Level
  • VRAX $3.26
  • SBEV $0.29
  • Average True Range (ATR)
  • VRAX 0.75
  • SBEV 0.04
  • MACD
  • VRAX -0.31
  • SBEV -0.01
  • Stochastic Oscillator
  • VRAX 9.18
  • SBEV 8.50

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About SBEV Splash Beverage Group Inc. (NV)

Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce segment. Qplash is a wholly owned division of Splash. It is the company's first entry point into the e-commerce channel. For beverage-alcohol products, the company operate within what is referred to as a "Three Tier Distribution System" where manufacturers are not permitted to sell directly to retailers, but instead, contract for local and regional distribution with independent distributors.

Share on Social Networks: